ADC Therapeutics SA
ADCT
$3.43
-$0.05-1.44%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 231.01M | 261.34M | 234.74M | 264.56M | 194.70M |
| Total Receivables | 31.05M | 29.12M | 22.92M | 26.18M | 31.76M |
| Inventory | 4.78M | 4.18M | 18.04M | 17.76M | 17.45M |
| Prepaid Expenses | 5.67M | 5.61M | 5.93M | 4.58M | 6.90M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.27M | 6.08M | 5.52M | 5.66M | 7.18M |
| Total Current Assets | 276.77M | 306.34M | 287.15M | 318.76M | 257.99M |
|
|
|||||
| Total Current Assets | 276.77M | 306.34M | 287.15M | 318.76M | 257.99M |
| Net Property, Plant & Equipment | 1.20M | 1.30M | 1.39M | 1.49M | 13.39M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 13.53M | 15.52M | 1.22M | 1.32M | 1.16M |
| Total Assets | 291.50M | 323.15M | 289.76M | 321.56M | 272.54M |
|
|
|||||
| Total Accounts Payable | 5.30M | 9.18M | 8.12M | 9.62M | 15.59M |
| Total Accrued Expenses | 38.07M | 43.34M | 43.25M | 42.67M | 31.42M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 19.54M | 3.54M | 933.00K | 1.79M | 1.37M |
| Total Finance Division Other Current Liabilities | 4.73M | 14.11M | 9.74M | 10.52M | 9.41M |
| Total Other Current Liabilities | 4.73M | 14.11M | 9.74M | 10.52M | 9.41M |
| Total Current Liabilities | 67.63M | 70.16M | 62.04M | 64.60M | 57.79M |
|
|
|||||
| Total Current Liabilities | 67.63M | 70.16M | 62.04M | 64.60M | 57.79M |
| Long-Term Debt | 415.73M | 434.98M | 455.38M | 447.72M | 440.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 991.00K | 1.03M | 1.13M | 1.26M | 7.91M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 23.53M | 2.81M | 9.39M | 7.17M | 4.45M |
| Total Liabilities | 507.87M | 508.98M | 527.94M | 520.75M | 510.76M |
|
|
|||||
| Common Stock & APIC | 1.45B | 1.45B | 1.39B | 1.39B | 1.29B |
| Retained Earnings | -1.67B | -1.64B | -1.63B | -1.59B | -1.53B |
| Treasury Stock & Other | -1.01M | -722.00K | -907.00K | -595.00K | -1.30M |
| Total Common Equity | -216.38M | -185.83M | -238.18M | -199.18M | -238.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -216.38M | -185.83M | -238.18M | -199.18M | -238.22M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -216.38M | -185.83M | -238.18M | -199.18M | -238.22M |
|
|
|||||